What is Aurora Cannabis Inc?
, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB · Verdict
Solid reward · elevated risk
ACB stands out on balance sheet and growth, but watch the cash flow signal.
Based on 88% data coverage
ACB · Verdict
Interest covered 3.4×
Revenue +15.8% CAGR
P/E 19.2×
-1% free-cash-flow margin
Below average
0% net margin · -16% ROE
Model-based scoring. For information only — not financial advice.
, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 205.76M.
The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.